Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
45
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Stomatitis And Everolimus: A Review Of Current Literature On 8,201 Patients

Claudia Arena1 Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalyORCID Iconhttps://orcid.org/0000-0001-7277-146X
ORCID Icon,
Giuseppe Troiano1 Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalyORCID Iconhttps://orcid.org/0000-0001-5647-4414
ORCID Icon,
Khrystyna Zhurakivska1 Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalyORCID Iconhttps://orcid.org/0000-0002-2153-0778
ORCID Icon,
Riccardo Nocini2 Section of Otolaryngology, Department of Surgical Sciences, Dentistry, Gynecology, and Pediatrics, University of Verona, Verona, ItalyORCID Iconhttps://orcid.org/0000-0001-5086-4390
ORCID Icon &
Lorenzo Lo Muzio1 Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy;3 C.I.N.B.O. (Consorzio Interuniversitario Nazionale per la Bio-Oncologia), Chieti, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4633-4893
ORCID Icon
Pages 9669-9683 | Published online: 14 Nov 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Avantika Singh, Aristides Hadjinicolaou, Jurriaan M Peters & Catherine L Salussolia. (2023) Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions. Neuropsychiatric Disease and Treatment 19, pages 733-748.
Read now

Articles from other publishers (5)

Alan Kivitz, Wesley DeHaan, Rehan Azeem, Justin Park, Sheri Rhodes, Jamie Inshaw, Sheldon S. Leung, Savvas Nicolaou, Lloyd Johnston, Takashi K. Kishimoto, Peter G. Traber, Earl Sands & Hyon Choi. (2023) Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110). Rheumatology and Therapy 10:4, pages 825-847.
Crossref
Dana Reynolds, Lauren M Mitteer, Winifred Sigal, Linda Boyajian, Heather McKnight, Tricia Bhatti, Lisa States, Susan Becker, N. Scott Adzick, Katherine Lord & Diva D. De Leon. (2023) Novel Use of Dasiglucagon, a Soluble Glucagon Analog, for the Treatment of Hyperinsulinemic Hypoglycemia Secondary to Suspected Insulinoma: A Case Report. Hormone Research in Paediatrics, pages 1-1.
Crossref
Catarina Ester Gomes Menezes, Débora Lopes dos Santos, Erick Santos Nery, Evelin Duarte Serpa, Lécio Aragão Souza Morais, Lucas Santana Dutra, Marcos Baruch Portela Filho & Julieta Sobreira Goes. (2023) Everolimus as a therapeutic option in refractory epilepsy in children with tuberous sclerosis: a systematic review. Arquivos de Neuro-Psiquiatria 81:04, pages 392-398.
Crossref
Yang Zhao, Yu Liu, Lin Zhou, Guo-Sheng Du & Qiang He. (2021) Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 13:9, pages 953-966.
Crossref
Caroline KinnearRahul AgrawalCaitlin Loo, Aric Pahnke, Deivid Carvalho RodriguesTadeo ThompsonOyediran AkinrinadeSamad Ahadian, Fred KeeleyMilica Radisic, Seema Mital & James Ellis. (2020) Everolimus Rescues the Phenotype of Elastin Insufficiency in Patient Induced Pluripotent Stem Cell–Derived Vascular Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 40:5, pages 1325-1339.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.